About Conference
On Tremendous success of our previous Cancer Conferences, The 4th World Congress on Cancer Research & Therapy will take place in the gorgeous city of Rome, Italy in August 13-15, 2018 and the theme of the conference is “Novel Discoveries in Cancer Research & Treatment”. World Cancer Congress(WCC)-2018 is designed to be a relaxed and friendly meeting where delegates and invited speakers have a chance to interact on both a scientific and social basis. We encourage the speakers to stay for the duration of the conference to ensure this interaction.
The development and progression of cancer involves complex interplay between the tumour itself and numerous other cell types and physiological processes. Thus, to study the mechanisms of malignancy in a way that is meaningful requires sophisticated in vivo models. This meeting will focus on the latest developments in the generation of animal models of cancer, and will put particular emphasis on how diverse aspects of the human disease may be faithfully recapitulated in the laboratory. We will discuss how these approaches have enabled us to assemble a whole-body view of cancer initiation and the processes that lead to the dissemination and spread of metastases.
Here are four reasons (Networking and developing new partnerships, Continuing education and skill development, Learning and sharing best practices and Advancement of the profession) why it is important for you to attend our World Cancer Conference.
A special invitation is extended to international colleagues to attend and contribute to the conference. Mark your calendars now and for more details please contact us at cancer@europeanconferences.org
Latest News
Lung Cancer ‘Dream Team’ to Merge Targeted Therapy, Immunotherapy
More than 35 of the top lung cancer researchers in the United States, dubbed the lung cancer “Dream Team,” are coming together to work on one of the most difficult-to-treat lung cancers – those that have a mutation in a gene called KRAS.
Overcoming Treatment Resistance in Advanced Prostate Cancer
Hormone therapy has long been the center of care for prostate cancer and helps many men diagnosed with the disease live longer. Such treatments reduce or block the production of androgens, the male sex hormones that help prostate cells grow and function, but which also fuel cancer cell growth.
Gene Discovery Offers Hope for Treating ER-positive Breast Cancer
Estrogen is an important female hormone that signals the breasts to form during puberty. It's a necessity for normal mammary gland development. Yet, in some cases, the hormone also helps abnormal breast cells to grow, giving rise to the most common subtype of breast cancer, called estrogen receptor-positive (ER-positive) disease.
Certain Parts of U.S. Rife With Opportunity to Reduce Colorectal Cancer Burden
Colorectal cancer incidence and death rates in the United States have declined significantly in recent decades. But not every part of the country has benefitted equally.
Aspirin and Cancer Prevention: What the Research Really Shows
The U.S. Preventive Services Task Force (USPSTF) last week released draft recommendations around the use of aspirin to help prevent disease, including both cardiovascular disease (heart attacks and strokes) and colorectal cancer. The inclusion of colorectal cancer as part of these guidelines is a first.
Organizing Committee
Xianming Mo
Director of Laboratory of Stem Cell Biology,West China Hospital, Sichuan University, China
Laszlo Tabar
Professor Emeritus of Radiology, Uppsala University, Sweden
Krupa Torne
Paediatric Neurologist Head, Department of Neurosciences Surya Children’s Hospital, India
Kinfe Ken Redda
Professor Emeritus of Medicinal Chemistry, Florida A&M University, USA
Sergey Roussakow
Director, Galenic Research Institute, Moscow, Russia
Scientific Sessions
Featured Speakers
Title: The constitution of Cancer tissues: the properties and implication of cancer stem cells derived from patients’ samples
Xianming Mo
West China Hospital, Sichuan University, China
Cancer Stem Cell Therapy
Title: Novel Reconstructive Options after Head and Neck Skin Cancer Resection.
Rajshree Jayarajan
University Hospitals of Leicester, UK
Radiation, Surgical and Medical oncology
Title: Targeting the CD200 Checkpoint Blockade: A New Direction for A New Direction for Immunotherapy
Michael Olin
University of Minnesota, USA
Cancer Immunology & Vaccines
Title: Epigenetic Regulation in Carcinogenesis and Combination Therapy
Sibaji Sarkar
Quincy College, USA
Cancer Genetics
Title: Imune cell restoration after various hematopoietic cell transplantation regimens in leukemia patients
Irina St. Louis
University of Minnesota, USA
Anti-Cancer Drug Discovery & Therapy
Title: Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small cell lung cancer
Yaodong Zhou
Shanghai Jiaotong University, China
Innovations in prevention and screening
Title: Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice
Zixing Wang
Pecking Union Medical College, China
Clinical Oncology
Title: A Proposal to Unify the Classification of Breast and Prostate Cancers Based on the Anatomic Site of Cancer Origin and on Long-term Patient Outcome
Laszlo Tabar
Uppsala University, Sweden
Breast Cancer Research
Title: miR-193a: potential therapeutic agent and circulating biomarker in cutaneous melanoma
Sara Carpi
University of Pisa, Italy
Cancer Genetics
Title: Genomic profiling of solid tumors and cell free DNA: research and clinical aspects.
Karina Eterovic
MD Anderson Cancer Center, USA
Clinical Oncology
Title: A CASE REPORT OF SQUAMOUS CELL CARCINOMA OF THE RENAL PELVIS INITIALLY PRESENTING AS RENAL ABSCESS
Christer Mari Taclobos
Corazon Locsin Montelibano Memorial Regional Hospital, philippines
Cancer Screening & Diagnosis
Title: A Case of Primary Pulmonary Monophasic Synovial Sarcoma
Larrie- Lyn Albarico
Corazon Locsin Montelibano Memorial Regional Hospital , philippines
Cancer Screening & Diagnosis
Title: Alisertib induced epigenetic activation of the STAT1 gene through a decrease in Aurora A-UHRF1 binding and induction of DNMT1 ubiquitination and degradation
Jing Yang
Xuzhou Medical University, China
Anti-Cancer Drug Discovery & Therapy
Title: Cancer Vaccines and the impact of g-irradiation on the induction of bystander killing by genetically engineered ovarian tumor cells: implications for clinical use.
Jehad Zweiri
University of Liverpool/Medical School, UK
Cancer Immunology & Vaccines
Title: RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer
Rui Zhou
The Third Affiliated Hospital of Southern Medical University, China
Clinical Oncology
Title: ISOLATED CUTANEOUS METASTASIS AS AN INITIAL PRESENTATION OF COLONIC ADENOCARCINOMA IN A 45 YEAR-OLD MALE: A CASE REPORT
Raye Angeli Abella
Corazon Locsin Montelibano Memorial Regional Hospital, Philippines
Organ Specific Cancers and Effects
Title: Synthesis and Biological Evaluation of Tetrahydroisoquinolines as Anti-Breast Cancer Agents
Kinfe Ken Redda
Florida A&M University, USA
Anti-Cancer Drug Discovery & Therapy
Title: Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: A systematic review and meta-analysis of observational studies
Zhuo Yang
Shengjing Hospital of China Medical University, China
Cancer Screening & Diagnosis
Title: The latest NCCN guidelines for cancer pain in Serbia
Ljiljana Gvozdenovi
University of Novi Sad, Serbia
Anti-Cancer Drug Discovery & Therapy
Title: SnoRNAs produce microRNA-like RNAs that contribute to malignancy
Glen Borchert
University of South Alabama, USA
Cancer Genetics
Title: A stage-dependent link between metabolic syndrome components and incident prostate cancer
Jan Hammarsten
University of Gothenburg, Sweden
Innovations in prevention and screening
Title: Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization
Ehsan Alirahimi
pasteur institute of Iran, Iran
Anti-Cancer Drug Discovery & Therapy
Title: Selective Internal Radiation Therapy (SIRT) in the Management of Primary and Metastatic Hepatic Malignancies
Navesh Sharma
Penn State Hershey Cancer Institute, USA
Radiation, Surgical and Medical oncology
Title: Hyperthermia in the treatment of soft tissue sarcoma: state of the art
Sergey Roussakow
Galenic Research Institute, Russia
Clinical Oncology
Title: Quantitative and Mechanistic Understanding of AZD1775 Penetration across Human Blood-Brain Barrier in Glioblastoma Patients Using an IVIVE-PBPK Modeling Approach
Jing Li
Karmanos Cancer Institute, Wayne State University, USA
Anticancer Drug Discovery and Therapy
Title: Glimpse into Immunotolerance and Migration in Early-stage Endometrial Carcinoma — Metabolomics-based Metabolites Screening and Functional Analyses
Kun Shi
Guangzhou Women and Children’s Medical Center, China
Clinical Oncology
Title: 3D breast cancer models grown from individual cells in vitro: effect of environmental stiffness
Elena Afrimzon
Bar Ilan University, Israel
Breast Cancer Research
Title: MHY446 induces apoptosis via ROS-mediated ER Stress in HCT116 human colorectal cancer cells
Nam Deuk Kim
Pusan National University, South Korea
Anti-Cancer Drug Discovery & Therapy
Title: CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis
Touko Asano
Omori Red Cross Hpspital, Japan
Cancer Immunology & Vaccines
Title: SCREENING FOR LUNG CANCER HAS LIMITED EFFECTIVENESS GLOBALLY AND DISTRACTS FROM MUCH NEEDED EFFORTS TO REDUCE CRITICAL LEVELS OF WORLDWIDE PREVALANCE OF SMOKING
Cherian Verghese
University of Toledo, USA
Organ Specific Cancers and Effects
Title: Consideration of reconstruction evolution in oral cancer- A change towards more functional results.
Parul Tandon
Pravara Institute of Medical Sciences, India
Surgical Oncology
Title: A six-gene index for subtype classification and prognosis in diffuse large B-cell lymphoma
Tong Wang
Shanxi medical university, China
Cancer Genetics
Title: Identifying mutually exclusive gene set with prognostic value and novel potential driver genes in patients with glioblastoma
Qian Gao
Shanxi medical univeraity, China
Cancer Genetics
Title: Biology of cell-free nucleic acids and their role in initiation and metastasis of cancer
Indraneel Mittra
Tata Memorial Centre, India
Clinical Oncology
Title: Phase I study of glasdegib (PF-04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies
Yosuke Minami
National Cancer Center Hospital East , Japan
Cancer Stem Cell Therapy
Title: Somatic cell reprogramming as a model of initiation of tumorigenesis
Karlen Gazarian
Mexican National University, Mexico
Cancer Stem Cell Therapy
Title: Lung Cancer in the Era of Precision Medicine
Neha Girish Sabnis
CORE Diagnostics, India
Clinical Oncology
Title: LIN28B increased tumorigenesis in a KRAS mutant mouse model of lung adenocarcinoma
Lydia Meder
University Hospital Cologne, Germany
Organ Specific Cancers and Effects
Title: St. John’s Wort Regulates Proliferation and Apoptosis in MCF-7 Human Breast Cancer Cells by Inhibiting AMPK/mTOR and Activatimg the Mitochondrial Pathway
Mikyoung You
University of Nebraska-Lincoln, USA
Breast Cancer Research
Title: Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients
Venus Dalal
AIIMS, India
Clinical Oncology
Title: Nanotechnolgy in cancer treatment
Devika Chithrani
University of Victoria, Canada
Cancer Screening & Diagnosis
Title: DEAD-BOX RNA HELICASE DP103 ENHANCES YAP SUMOYLATION FOR YAP-TEAD DEPENDENCE AND STATIN SENSITIVITY IN TRIPLE NEGATIVE BREAST CANCER
Alan Prem Kumar
National University of Singapore, Singapore
Breast Cancer Research
Title: Protein profiling of extracellular vesicles harvested from therapeutic induced senescent triple negative breast cancer cells
Amanda McCann
University College Dublin, Ireland
Breast Cancer Research
Title: The Impact of a Bayesian Penalized-Likelihood Reconstruction Algorithm on Delayed-Time-Point Ga-68-PSMA PET for Improved Recurrent Prostate Cancer Detection
Tiago Sampaio Vieira,
Lenitudes Medical Center & Research, Portugal
Clinical Oncology
Title:Role of p21 activated kinase 1 in tumour immune response
Hong He
University of Melbourne, Australia
Clinical Oncology
Title: Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia
Hong Zhou
Huazhong University of Science and Technology, China
Anti-Cancer Drug Discovery & Therapy
Title: HPV prevalence and HPV-related dysplasia in elderly women Introduction
Annika Lindström
Center for Clinical Research Dalarna, Uppsala University, Sweden
Cancer Screening & Diagnosis
Title: Sulfide signaling is involved in apoptosis induction in solid tumor cells
Olga Krizanova
Biomedical Research Center, Slovak academy of Sciences, Slovakia
Anti-Cancer Drug Discovery & Therapy
Title: Preclinical activity of abemaciclib alone or in combination with anti-mitotic and targeted therapies in breast cancer
Neil OBrien
University of California, Los Angeles, USA
Breast Cancer Research
Title: Is Preoperative Histopathological Diagnosis Really Useless in Patients with Radiological Diagnosis of Periampullary Carcinoma?
Yusuf Gunay
Bulent Ecevit University, Turkey
Cancer Screening & Diagnosis
Title: Personalized approach to patient with colorectal cancer liver metastasis
Judita Kinkorova
University Hospital Pilsen, Czech Republic
Organ Specific Cancers and Effects
Title: Multi-criteria optimization achieves superior normal tissue sparing in intensity-modulated radiation therapy for oropharyngeal cancer patients
Jianghong Xiao
Sichuan University , China
Innovations in prevention and screening
Title: ZFP521 contributes to pre-B-cell lymphoma genesis through modulation of the Pre-B-cell receptor signaling pathway
Tatsuaki Tsuruyama
Kyoto University, Japan
Cancer Genetics
Title: Studies on non-steroidal inhibitors of aromatase enzyme; 4-(aryl/heteroaryl)-2-(pyrimidin-2-yl)thiazole derivatives
Zafer Sahin
Istanbul Medipol University, Turkey
Anti-Cancer Drug Discovery & Therapy
Title: Molecular profiling-selected treatment in metastatic cancer: can we change our standard of practice
Ofer Purim
Chief Gastrointestinal Malignancy Service, Assuta Samson Hospital, Israel
Anti-Cancer Drug Discovery & Therapy
Title: GOLPH3 promotes human glioma progression via inhibiting endocytosis and degradation of EGFR
Xiuping Zhou
Xuzhou Medical University, China
Cancer Genetics
Title: Dose distribution after tumor cavity injection in brain glioma patients
Ming Zhao
First Affiliated Hosptial of Chinese PLA General Hospital, China
Clinical Oncology
Title: Fusion Antibody (scFv-MICA) is the suitable Therapeutic Agent for Acute Myeloid Leukemic (AML) Cells that Express NKG2D to Escape Immune-Surveillance
Desmond Omane Acheampong
University of Cape Coast , Ghana
Anti-Cancer Drug Discovery & Therapy
Past Conference Gallery
Target Audience
Oncologists
Academic Professors
Cancer Researchers
Chemotheraphists
Radiologists
Pathologists
Physicians
Breast Cancer
Surgeons
Why to attend ?
- To Meet renowned speakers, world's leading CEO's, Directors, decision and policy makers.
- To know about the ongoing research projects for cancer diagnosis and treatment
- To keep abreast of all advances in Cancer field
- Chance to collaborate research organizations with industries
- To share the research ideas and implement them
- Best opportunity to reach the largest assemblage of participants from cancer community
- New contacts to enhance the business opportunities
